Showing 11,021 - 11,040 results of 11,583 for search '"Sichuan University"', query time: 0.25s Refine Results
  1. 11021
  2. 11022
  3. 11023
  4. 11024
  5. 11025
  6. 11026
  7. 11027
  8. 11028
  9. 11029
  10. 11030
  11. 11031
  12. 11032
  13. 11033
  14. 11034

    Cryptococcosis in Southern China: Insights from a Six-Year Retrospective Study in Eastern Guangdong by Bilal H, Zhang D, Shafiq M, Khan MN, Chen C, Khan S, Wang Q, Cai L, Awais M, Hu H, Zeng Y

    Published 2023-07-01
    “…Hazrat Bilal,1 Dongxing Zhang,2,3 Muhammad Shafiq,4 Muhammad Nadeem Khan,5 Canhua Chen,6 Sabir Khan,1 Qian Wang,1,7 Lin Cai,1 Muhammad Awais,8 Haibin Hu,9 Yuebin Zeng1,10 1Department of Dermatology, Second Affiliated Hospital of Shantou University Medical College, Shantou, 515041, People’s Republic of China; 2Department of Dermatology, Meizhou Dongshan Hospital, Meizhou, Guangdong Province, 514023, People’s Republic of China; 3Department of Dermatology, Meizhou People’s Hospital, Meizhou, Guangdong Province, 514023, People’s Republic of China; 4Department of Cell Biology and Genetics, Shantou University Medical College, Shantou, People’s Republic of China; 5Faculty of Biological Sciences, Department of Microbiology, Quaid-I-Azam University, Islamabad, 45320, Pakistan; 6Clinical Laboratory, Meizhou People’s Hospital, Meizhou, Guangdong Province, 514023, People’s Republic of China; 7Department of Medical-Surgical and Experimental Sciences University of Sassari Neurology Unit, Azienda Ospedaliera Universitaria (AOU), Sassari, Italy; 8Department of Environmental Science and Engineering, Kunming University of Science and Technology, Kunming, Yunnan, People’s Republic of China; 9The First Clinical Medical college, Guangdong Medical University, Zhanjiang, 523808, People’s Republic of China; 10Department of Dermatology, West China Second University Hospital, Sichuan University, Chengdu, Sichuan, 610021, People’s Republic of ChinaCorrespondence: Yuebin Zeng, Tel +8618607549813, Email zeng_yb@163.comObjective: Cryptococcosis is a fatal infection that can affect both immunocompetent and immunocompromised patients, and it is little understood in China’s various regions. …”
    Get full text
    Article
  15. 11035
  16. 11036
  17. 11037

    Patient Preferences For Chemotherapy In The Treatment Of Non-Small Cell Lung Cancer: A Multicenter Discrete Choice Experiment (DCE) Study In China by Sun H, Wang H, Xu N, Li J, Shi J, Zhou N, Ni M, Hu X, Chen Y

    Published 2019-10-01
    “…Hui Sun,1,2 Huishan Wang,3 Ningze Xu,1 Junling Li,4 Jufang Shi,4 Naitong Zhou,5 Ming Ni,6 Xianzhi Hu,7 Yingyao Chen1 1Key Lab of Health Technology Assessment, National Health Commission, School of Public Health, Fudan University, Shanghai, People’s Republic of China; 2Department of Health Technology Assessment Research, Shanghai Health Development Research Center, Shanghai Medical Information Center, Shanghai, People’s Republic of China; 3The Second Clinical Medical School of Nanjing Medical University, Nanjing, People’s Republic of China; 4Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, People’s Republic of China; 5West China School of Pharmacy, Sichuan University, Chengdu, People’s Republic of China; 6Fudan University Shanghai Cancer Center, Shanghai, People’s Republic of China; 7Sun Yat-Sen University Cancer Center, Guangzhou, People’s Republic of ChinaCorrespondence: Yingyao ChenSchool of Public Health, Fudan University, Shanghai 200032, People’s Republic of ChinaTel +86-21-33565183Fax +86-21-64169552Email yychen@shmu.edu.cnObjective: The study aims to quantify patients’ risk-benefit preferences for chemotherapy in the treatment of non-small cell lung cancer (NSCLC), and to elicit their willingness to pay (WTP) for treatment outcomes.Methods: A face-to-face discrete choice experiment (DCE) was conducted on NSCLC patients in four tertiary hospitals each from Beijing, Shanghai, Guangzhou and Chengdu in China. …”
    Get full text
    Article
  18. 11038
  19. 11039
  20. 11040